Impact of Community-based Boxing Exercises in Individuals With Chronic Stroke

November 6, 2026 updated by: Texas Woman's University

Impact of Community-based Non-contact Boxing Exercise on Individuals With Chronic Stroke - a Pilot Study

The purpose of this study is to examine if non-contact boxing exercises improve balance, physical performance, quality of life and physical activity in adults with chronic stroke. It will also learn about the physical activity trend in adults with chronic stroke. The main research questions of the study are:

  • Do community-based non-contact boxing exercises improve the balance in participants with chronic stroke?
  • How is the exercise intensity of boxing exercises in individuals with chronic stroke? Researchers will test one group of participants without a comparison group.

Participants will need to complete the following tasks over 8 weeks:

  • Participate in the boxing exercise program once per week for 8 weeks
  • Attend two evaluation sessions: the initial and the final evaluation sessions.
  • Keep a diary of their daily step counts
  • Learn to assess their own physical fatigue and mental fatigue level during boxing exercise sessions.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Each participant will receive a pedometer at the end of the initial evaluation session of the study. The pedometer will be used to track their daily step count. After 8 weeks, each participant will receive a gift card with a nominal value at the final evaluation session.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
40

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.
  • Name: Suh-Jen Lin, PT, PhD
  • Phone Number: 2146897718
  • Email: slin@twu.edu

Study Contact Backup

  • Name: Jyutika Mehta, PhD
  • Phone Number: 214-689-6508
  • Email: jmehta@twu.edu

Study Locations

  • United States
    • Texas
      • Dallas, Texas, United States, 75235
        • Recruiting
        • The Mike A. Myers Stoke Center of Texas Woman's University - Dallas
        • Contact:
        • Contact:
          • Suh-Jen Lin, PhD
          • Phone Number: 214-689-7718
          • Email: slin@twu.edu
        • Principal Investigator:
          • Suh-Jen Lin, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

(1) Adults (age 18-80 years): (2) With chronic stroke (over 9 months), (3) Walk independently with or without an assistive device for a household distance (4) Montreal Cognitive Assessment (MoCA) score 23 or higher, (5) Self-report doing fine in daily activities (6) have passed the fall risk screening by the instructor (a physical therapist) of exercise program at the TWU Stroke Center to participate in the community-based group exercises.

Exclusion Criteria:

  • with a hospital admission in 3 months,
  • impaired cognition (MoCA score 22 or less)
  • Dyspnea at rest
  • with fever or self-report palpitation
  • cannot walk for a household distance with an assistive device
  • Currently active participation in other community exercise programs., receiving training at a physical therapy clinic, or self-exercise regularly on their own
  • Inability to participate in one hour of low- to moderate-intensity exercise, even with frequent short breaks
  • did not pass the fall risk screening during physical therapy examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Non-contact boxing exercise

non-contact group boxing exercises will be delivered at a community setting.
Behavioral: Community-based non-contact boxing group exercise

The non-contact boxing exercise in delivered as a group once per week at a community-based setting for 8 weeks

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The ABC scale
Time Frame: 8 weeks

The ABC scale is to assess balance confidence while performing various tasks without losing balance or feeling a state of unsteadiness. Some activities in the test include walking around the house, using stairs, reaching for objects, standing, and getting in and out of a car.
8 weeks
PHQ-9
Time Frame: 8 weeks

The PHQ-9 is a 9-item questionnaire used to screen for the severity of depression based on Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria. Each item is scored 0-3, reflecting how often symptoms occurred over the past two weeks.
8 weeks
The Berg Balance Scale
Time Frame: 8 weeks

The Berg Balance Scale is a 14-item assessment that assesses static and functional balance in adults in order to determine fall risk. It consists of standing, sitting, and sit-to-stand while unsupported. The test also includes maintaining balance while reaching and head turning.
8 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The 10-Meter Walk Test
Time Frame: 8 weeks

The 10-Meter Walk Test is a gait speed assessment that requires the participant to walk 6 meters. Participants are asked to walk as fast as possible while maintaining their balance. They will be given 2 trials and gait speed will be calculated by taking the average of the two trials.
8 weeks
Modified Clinical Test of Sensory Interaction on Balance:
Time Frame: 8 weeks

Modified Clinical Test of Sensory Interaction on Balance: This computerized test assesses an individual's postural sway and risk of falls at different conditions (30 seconds each): eyes open/firm surface, eyes closed/firm, eyes open/foam surface. eyes closed/foam surface. There are rails on both side of the platform that the participant can hold onto when needed, and two researchers will guard the participant with a gait belt.
8 weeks
Physical activity
Time Frame: 8 weeks

Participants will wear a pedometer to track their daily step count and record on the activity log (on paper) over 8 weeks. The research team will call them every week to collect their previous 7-day step count data.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Texas Woman's University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Holly Hansen-Thomas, PhD, Texas Woman's University- Denton

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 28, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 31, 2028

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 31, 2028

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 6, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 6, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 12, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 6, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IRB-FY 2026-141

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The study protocol and statistical plan will be shared.

IPD Sharing Time Frame

The IPD will be shared after completing the study (8/31/2028) for 3 years.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings